Publications by authors named "Edwin B Walker"

Claim this Profile
D
Defining a functionally distinct subset of human memory CD4+ T cells that are CD25POS and FOXP3NEG.
Todd A Triplett, Brendan D Curti, Peter R Bonafede, William L Miller, Edwin B Walker

Eur J Immunol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring cytokine profiles during immunotherapy.
Janet C Siebert, Edwin B Walker

Immunotherapy· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exhaustive expansion: A novel technique for analyzing complex data generated by higher-order polychromatic flow cytometry experiments.
Janet C Siebert, Lian Wang, Daniel P Haley, Ann Romer, Bo Zheng, Edwin B Walker

J Transl Med· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signaling through OX40 enhances antitumor immunity.
Shawn M Jensen, Levi D Maston, Michael J Gough, Carl E Ruby, William L Redmond, Edwin B Walker

Semin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice.
Li-Xin Wang, Yuhuan Li, Guojun Yang, Pui-yi Pang, Dan Haley, Edwin B Walker

Eur J Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts.
Christian H Poehlein, Daniel P Haley, Edwin B Walker, Bernard A Fox

Eur J Immunol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.
Ulf Petrausch, Shawn M Jensen, Christopher Twitty, Christian H Poehlein, Daniel P Haley, Edwin B Walker

J Immunol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.
Ulf Petrausch, Christian H Poehlein, Shawn M Jensen, Chris Twitty, James A Thompson, Edwin B Walker

Curr Mol Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood.
Edwin B Walker, William Miller, Daniel Haley, Kevin Floyd, Brendan Curti

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.
Edwin B Walker, Daniel Haley, Ulf Petrausch, Kevin Floyd, William Miller

Clin Cancer Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.
Dominik Rüttinger, Rui Li, Christian H Poehlein, Dan Haley, Edwin B Walker

J Immunother· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model.
Hong He, Preya Wisner, Guojun Yang, Hong-Ming Hu, Dan Haley, Edwin B Walker

J Transl Med· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring immune responses in cancer patients receiving tumor vaccines.
Edwin B Walker, Mary L Nora Disis

Int Rev Immunol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
Edwin B Walker, Daniel Haley, William Miller, Kevin Floyd, Ketura P Wisner

Clin Cancer Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses.
John W Smith, Edwin B Walker, Bernard A Fox, Daniel Haley, Ketura P Wisner

J Clin Oncol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis